Amwill Health Care Ltd (AMWILL)

About

Amwill Health Care Ltd operates in Pharmaceuticals within the Healthcare sector.

Face value: ₹10

Market cap

₹86 Cr

P/E

7.5×

P/B

—

Dividend yield

1.2%

ROE

—

ROCE

—

Debt / equity

—

OPM

28.6%

EPS (TTM)

₹5.7

Book value

—

52-week high

—

52-week low

—

378 historical price candles were omitted because the exchange source has not been verified.

₹43.0-2.3%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 28.6%
+High promoter holding of 70.7% with no pledge

Cons

−Low dividend payout of 8.8% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

89/100

Business quality: 79
Valuation: 100

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Torrent Pharmaceuticals LimitedTORNTPHARMTORNTPHARM	₹1,61,325 Cr	₹1,76,123 Cr	₹15,723 Cr	₹5,191 Cr	32.6%	₹2,181 Cr	15.3%	14.5%	27.1%	163
Zydus Lifesciences LimitedZYDUSLIFEZYDUSLIFE	₹1,14,284 Cr	₹1,26,053 Cr	₹28,592 Cr	₹8,316 Cr	31.2%	₹4,513 Cr	18.9%	23.4%	19.7%	212
Laurus Labs LimitedLAURUSLABSLAURUSLABS	₹1,07,176 Cr	₹1,09,573 Cr	₹7,270 Cr	₹2,034 Cr	26.1%	₹1,093 Cr	13.1%	21.3%	18.2%	263
Mankind Pharma LimitedMANKINDMANKIND	₹1,04,696 Cr	₹1,11,007 Cr	₹14,738 Cr	₹3,827 Cr	25.3%	₹2,068 Cr	13.6%	14.2%	12.5%	117
Aurobindo Pharma LimitedAUROPHARMAAUROPHARMA	₹97,389 Cr	₹1,05,065 Cr	₹34,935 Cr	₹7,085 Cr	20.3%	₹3,713 Cr	10.4%	14.7%	9.9%	252
Lupin LimitedLUPINLUPIN	₹92,866 Cr	₹98,777 Cr	₹29,967 Cr	₹9,538 Cr	31.5%	₹5,529 Cr	19.2%	34.2%	26.9%	181
Glenmark Pharmaceuticals LimitedGLENMARKGLENMARK	₹65,781 Cr	₹65,781 Cr	₹17,737 Cr	₹4,797 Cr	26.9%	₹1,496 Cr	8%	37.8%	0%	83
Alkem Laboratories LimitedALKEMALKEM	₹62,431 Cr	₹64,055 Cr	₹15,081 Cr	₹3,032 Cr	20.4%	₹2,158 Cr	16%	21.5%	17.8%	152
Biocon LimitedBIOCONBIOCON	₹60,413 Cr	₹75,238 Cr	₹17,321 Cr	₹3,536 Cr	20.4%	₹495 Cr	2.2%	3.9%	1.4%	85
Abbott India LimitedABBOTINDIAABBOTINDIA	₹56,901 Cr	—	₹4,310 Cr	₹921 Cr	27.3%	₹691 Cr	22.4%	44.1%	34.5%	110
Ipca Laboratories LimitedIPCALABIPCALAB	₹49,299 Cr	₹50,003 Cr	₹10,126 Cr	₹2,232 Cr	20.5%	₹1,310 Cr	12.3%	17.8%	15.2%	308
Gland Pharma LimitedGLANDGLAND	₹47,428 Cr	₹47,671 Cr	₹6,725 Cr	₹1,751 Cr	25.3%	₹1,129 Cr	16%	14.8%	10.5%	255

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2025	Mar 2026
	41	45
COGS	12	14
Gross profit	29	32
	17	19
Operating profit (EBITDA)	12	13
OPM %	28.7%	28.6%
Depreciation	0	1
Interest	0	0
	1	3
Profit before tax	12	15
Tax	1	4
Tax %	9.8%	25.6%
	11	11
PAT margin %	26.4%	25.1%
EPS (₹)	0	5.7
	—	8.8%
Annual report	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2025	Mar 2026
Equity capital	—	—
Reserves	—	—
Borrowings	—	—
	71	87
Total equity & liabilities	71	87
Fixed assets	1	1
CWIP	—	—
Investments	0	0
	70	86
Total assets	71	87

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	306	6	8
	-300	-46	6
	1	41	-0
Net cash flow	6	1	14
Free cash flow	—	5	7
CFO / Operating profit %	—	47.7%	61.6%

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 12%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: 6%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2025	Mar 2026
Margins
Gross margin %	71.6%	70.1%
EBITDA margin %	28.7%	28.6%
EBIT margin %	27.6%	27.3%
PAT margin %	26.4%	25.1%
Working capital
Receivable days	—	—
Inventory days	17	22
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	11.09	12.4
Debt to EBITDA	—	—
Debt to equity	—	—
Interest coverage	—	—
Asset turnover	0.57	0.52
Return ratios
Return on assets %	15%	13.2%
Return on capital employed %	17.1%	20.4%
Return on equity %	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Dec 2024	Mar 2025	Sep 2025	Mar 2026
	70.65%	70.65%	70.65%	70.65%
	3%	1.16%	1.16%	0%
	2.13%	0%	0%	0%
Government	0%	0%	0%	0%
	24.22%	28.19%	28.19%	29.35%
No. of shareholders	2,401	1,374	1,606	1,483

Promoter holding up 0 percentage points since Dec 2024.

1 deal · 21 Aug 2026 – 21 Aug 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
21 Aug 2026	GLOBALWORTH SECURITIES LIMITED	Bulk	BSE	Sell	1,00,800	₹43.26	₹0.44 Cr

1–1 of 1

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Tarun GandhiDirector
Mr. Anand GandhiDirector
Mr. Man Singh GilundiaDirector
Ms. Sapna ParmarNon - Executive Non -Independent Director
Mr. Vasanth KumarNon-Executive - Independent Director
Mrs. Anshu AnshumanCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Amwill Health Care Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

6

Annual reports

2

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Final dividend7 Aug 2026 · ex-date₹0.5

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

1 announcementsExport CSV

28 Sept 2026, 1:09 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

Loading announcements…

Amwill Health Care Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Dividends1

Announcements

Not in the F&O segment

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Dividends1

No fund holdings on record

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

1

1